share_log

Barclays Maintains Overweight on Solid Biosciences, Raises Price Target to $21

Moomoo 24/7 ·  Mar 18 06:25

Barclays analyst Gena Wang maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and raises the price target from $8 to $21.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment